BRIEF published on 04/03/2024 at 14:05, 1 year 10 months ago Clairvoyant Therapeutics Advances Psilocybin Clinical Trial for Alcohol Use Disorder Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder Regulatory Pathway
BRIEF published on 04/03/2024 at 14:05, 1 year 10 months ago Clairvoyant Therapeutics fait progresser l'essai clinique sur la psilocybine pour les troubles liés à la consommation d'alcool Essai Clinique Thérapeutique Clairvoyante Traitement À La Psilocybine Trouble Lié À La Consommation D'alcool Voie Réglementaire
PRESS RELEASE published on 04/03/2024 at 14:00, 1 year 10 months ago Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization Clairvoyant Therapeutics aims to commercialize psilocybin treatment for alcohol use disorder by 2025. Company's trial progressing well, expecting results in 2024 & financing round underway Commercialization Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder
PRESS RELEASE published on 11/29/2023 at 13:00, 2 years 2 months ago Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
PRESS RELEASE published on 03/20/2023 at 12:00, 2 years 10 months ago First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder
Published on 02/18/2026 at 15:15, 1 hour 43 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 1 hour 58 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 2 hours 33 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 2 hours 58 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 2 hours 58 minutes ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 15:50, 1 hour 8 minutes ago CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 15:48, 1 hour 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 02/18/2026 at 15:47, 1 hour 11 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Published on 02/18/2026 at 15:46, 1 hour 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Published on 02/18/2026 at 15:44, 1 hour 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC
Published on 02/18/2026 at 13:45, 3 hours 13 minutes ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Published on 02/18/2026 at 11:00, 5 hours 58 minutes ago Mise à disposition des documents préparatoires à l'AG
Published on 02/18/2026 at 08:07, 8 hours 51 minutes ago TERACT - Modification du calendrier financier